PUBERTY BLOCKERS & FERTILITY
Puberty blockers pause puberty, and on their own, their effect is considered reversible: when the medication stops, puberty resumes, and the temporary pause in egg and sperm maturation ends. The fertility question is really about what comes next. If a young person starts the medication early in puberty and then moves on to gender-affirming hormones without a period of their own puberty in between, eggs or sperm may not have matured, which can limit the standard ways of preserving fertility later. That is why major medical groups recommend talking through fertility before any treatment begins.
This page uses “puberty-pausing medications” for the treatment after the first mentions; you may also see them called puberty blockers or puberty suppression, which mean the same thing. The broader category is sometimes called gender-affirming care, transition-related care, or supportive care, and those terms describe the same thing.
CONTENT NOTE
This is information, not medical advice. Whether this medication is appropriate for a particular young person is a decision for that young person, their family, and their qualified healthcare providers, based on individual circumstances.
-
On their own, effects are reversible. Puberty-pausing medications pause puberty; when they stop, puberty generally resumes, and the temporary pause in egg and sperm maturation ends.
-
The pathway is what matters. Going from early puberty-pausing medication straight to gender-affirming hormones can mean eggs or sperm never fully mature, which limits standard fertility preservation.
-
Counseling comes first. The Endocrine Society, WPATH, and the American Society for Reproductive Medicine recommend discussing fertility and preservation options before starting.
-
Options exist, with limits by age. Sperm banking and egg freezing work for those who have gone through enough puberty; tissue freezing is still experimental for younger youth.
-
The evidence is still thin. High-quality long-term fertility data are limited, which is exactly why counseling and individual planning matter.
KEY TAKEAWAYS
DO PUBERTY-PAUSING MEDICATIONS AFFECT FERTILITY?
On their own, puberty-pausing medications are understood to pause fertility temporarily, not end it. They work by pausing the hormone signals that drive puberty, which also pauses the maturation of eggs and sperm for as long as they are taken. When the medications are stopped without other treatment, puberty resumes, usually within months (Frontiers in Endocrinology, 2024). Because the same medications have been used for decades to treat unusually early puberty, there is long clinical experience with puberty restarting after they are stopped
(Mayo Clinic).
WHAT THE RESEARCH SHOWS
The key distinction is between these medications alone and the full treatment pathway. Direct, high-quality evidence on long-term fertility is limited; a 2025 systematic review that assessed the evidence using the GRADE approach found no moderate- or high-quality studies on fertility specifically (systematic review, 2025). The picture below reflects what is well understood about how the treatments work, together with what medical guidelines advise.
DURING THE PAUSE: DENSITY SCORES DECLINE
WHAT IS KNOWN, AND WHAT ISN'T
The reversibility of the medication itself is well supported by decades of use in early puberty. Less certain is long-term fertility after the full pathway, both because high-quality studies are limited and because many young people understandably do not want to pause treatment to let eggs or sperm mature. Researchers are studying experimental approaches, such as maturing eggs or sperm from tissue collected during early puberty, but these are not yet standard care (Current Concepts, 2024).
One practical point families sometimes miss: testosterone is not a reliable form of birth control. Trans masculine people on testosterone can still become pregnant, so contraception matters if pregnancy is possible (LGBT Health, 2019).
FERTILITY PRESERVATION OPTIONS
The established options are sperm banking, egg (oocyte) freezing, and embryo freezing. These generally require enough pubertal development to have produced mature sperm or eggs. For younger youth who have not been through puberty, freezing ovarian or testicular tissue is the main possibility, and it is still experimental (Best Practice & Research Clinical Obstetrics & Gynaecology, 2025). Access barriers are real and worth planning around: cost, the emotional difficulty of the process, and timing. A 2025 study found that many trans adults who had started testosterone by age 18 could not recall a fertility conversation beforehand, which is part of why current guidelines stress early, clear counseling (reported in Endocrinology Advisor, 2026).
This is information, not medical advice. Whether and how to preserve fertility for a particular young person is a decision for that young person, their family, and their qualified healthcare providers, ideally including a fertility specialist, before treatment begins.